{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:38:06Z","timestamp":1776775086254,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015293","name":"Policy-Based Medical Services Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jiac.2026.102957","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:13:07Z","timestamp":1775135587000},"page":"102957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of carbapenem and non-carbapenem empirical therapy for Klebsiella pneumoniae Bacteremia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-8008","authenticated-orcid":false,"given":"Yoshimichi","family":"Koutake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Airi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Adaniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6183-4939","authenticated-orcid":false,"given":"Toshinobu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102957_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcimb.2018.00004","article-title":"Colonization, infection, and the accessory genome of Klebsiella pneumoniae","volume":"8","author":"Martin","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2026.102957_bib2","article-title":"Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2026.102957_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01206-19","article-title":"Clinical and molecular characteristics of Klebsiella pneumoniae isolates causing bloodstream infections in Japan: occurrence of hypervirulent infections in health care","volume":"57","author":"Harada","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102957_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12941-024-00700-8","article-title":"Differences in clinical outcomes of bloodstream infections caused by klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study","volume":"23","author":"Guedes","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2026.102957_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/23744235.2024.2374980","article-title":"Incidence, antimicrobial resistance and mortality of Klebsiella pneumoniae bacteraemia in shanghai, China, 2018\u20132022","volume":"56","author":"Xiao","year":"2024","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jiac.2026.102957_bib6","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.3390\/ijerph17176278","article-title":"The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae","volume":"17","author":"Wang","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.jiac.2026.102957_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/joim.13007","article-title":"Hypervirulent Klebsiella pneumoniae\u2014Clinical and molecular perspectives","volume":"287","author":"Choby","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jiac.2026.102957_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/ph18050724","article-title":"Hypervirulent Klebsiella pneumoniae: insights into virulence, antibiotic resistance, and fight strategies against a superbug","volume":"18","author":"Hetta","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jiac.2026.102957_bib9","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001462","article-title":"Jmm profile: carbapenems: a broad-spectrum antibiotic","volume":"70","author":"Armstrong","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jiac.2026.102957_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.cmi.2019.03.030","article-title":"Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae in different groups of patients","volume":"25","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.102957_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/antibiotics12020399","article-title":"Evidence-based treatment of pseudomonas aeruginosa infections: a critical reappraisal","volume":"12","author":"Karruli","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.102957_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13756-018-0430-1","article-title":"Association between antibiotic consumption and the rate of carbapenem-resistant gram-negative bacteria from China based on 153 tertiary hospitals data in 2014","volume":"7","author":"Yang","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiac.2026.102957_bib13","first-page":"DC08","article-title":"Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates","volume":"9","author":"Joseph","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"Supplement 7","key":"10.1016\/j.jiac.2026.102957_bib14","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102957_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2024.07.015","article-title":"Effects of meropenem supply restriction: a multicenter retrospective study","volume":"31","author":"Koutake","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.102957_bib16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018ezr\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2026.102957_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-021-03736-w","article-title":"Initial antimicrobial management of sepsis","volume":"25","author":"Niederman","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2026.102957_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00846-25","article-title":"Carbapenems versus non-carbapenems as definitive treatment for hypervirulent Klebsiella pneumoniae bacteremia in Taiwan","volume":"69","author":"Juan","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102957_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/antibiotics9020061","article-title":"Carbapenem-sparing strategies for ESBL producers: when and how","volume":"9","author":"Karaiskos","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.102957_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20030857","article-title":"A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications","volume":"199","author":"Fang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jiac.2026.102957_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00547","article-title":"Hypermucoviscous Klebsiella pneumoniae: a challenge in community acquired infection","volume":"17","author":"S\u00e1nchez-L\u00f3pez","year":"2019","journal-title":"IDCases"},{"key":"10.1016\/j.jiac.2026.102957_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.20411\/pai.v10i1.777","article-title":"Hypervirulent Klebsiella pneumoniae (hvkp): overview, epidemiology, and laboratory detection","volume":"10","author":"Al Ismail","year":"2024","journal-title":"Pathog Immun"},{"key":"10.1016\/j.jiac.2026.102957_bib23","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/s41467-025-57379-4","article-title":"Genomically defined hypervirulent Klebsiella pneumoniae contributed to early-onset increased mortality","volume":"16","author":"Tang","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2026.102957_bib24","article-title":"Mortality risk of carbapenem-resistant hypervirulent Klebsiella pneumoniae vs. classical cr-kp: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.jiac.2026.102957_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijantimicag.2011.07.016","article-title":"Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists","volume":"38","author":"Daneman","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.102957_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1421","article-title":"Seven vs fourteen days of antibiotics for gram-negative bloodstream infection: a systematic review and noninferiority meta-analysis","volume":"8","author":"Lee","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2026.102957_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"Daneman","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102957_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2016.06.002","article-title":"Is de-escalation of antimicrobials effective? A systematic review and meta-analysis","volume":"49","author":"Ohji","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.102957_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial","volume":"40","author":"Leone","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2026.102957_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s15010-012-0388-5","article-title":"De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat gram-negative bacilli","volume":"41","author":"Shime","year":"2013","journal-title":"Infection"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:41:56Z","timestamp":1776771716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1341321X26000553"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102957","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of carbapenem and non-carbapenem empirical therapy for Klebsiella pneumoniae Bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102957"}}